Acrivon Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $1.30-$10.29 |
Market Cap | $58M |
Shares Short | 887,113 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.38 |
News
See moreYahoo Finance • 11 days ago
Acrivon Therapeutics Appoints World-Renowned Oncology Key Opinion Leader and Clinical Investigator Mansoor Raza Mirza, M.D., as Chief Medical Officer
Yahoo Finance • 22 days ago
Acrivon Therapeutics Provides Program Updates and Fourth Quarter and Full Year 2024 Financial Results
About
CEO | Dr. Peter Blume-Jensen M.D., Ph.D. |
CFO | Dr. Adam D. Levy M.B.A., Ph.D. |
Address | 480 Arsenal Way, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 75 |
